These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34689966)

  • 1. Blood Product (Donor) Noninfectious and Infectious Testing and Modification.
    Sarker T; Katz LM; Bloch EM; Goel R
    Clin Lab Med; 2021 Dec; 41(4):579-598. PubMed ID: 34689966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leveraging Donor Populations to Study the Epidemiology and Pathogenesis of Transfusion-Transmitted and Emerging Infectious Diseases.
    Bloch EM; Busch MP; Corash LM; Dodd R; Hailu B; Kleinman S; O'Brien S; Petersen L; Stramer SL; Katz L
    Transfus Med Rev; 2023 Oct; 37(4):150769. PubMed ID: 37919210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efforts Toward Elimination of Infectious Agents in Blood Products.
    Jacquot C; Delaney M
    J Intensive Care Med; 2018 Oct; 33(10):543-550. PubMed ID: 29562814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Update on infectious risks associated with blood products].
    Traineau R; Elghouzzi MH; Bierling P
    Rev Prat; 2009 Jan; 59(1):86-9. PubMed ID: 19253889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ensuring safety of the blood supply in the United States: Donor screening, testing, emerging pathogens, and pathogen inactivation.
    Godbey EA; Thibodeaux SR
    Semin Hematol; 2019 Oct; 56(4):229-235. PubMed ID: 31836028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood transfusion: control of infectious risks].
    Laperche S; Lefrère JJ; Morel P; Pouchol E; Pozzetto B
    Presse Med; 2015 Feb; 44(2):189-99. PubMed ID: 25547992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-Borne Pathogens: A Canadian Blood Services Centre for Innovation Symposium.
    Walsh GM; Shih AW; Solh Z; Golder M; Schubert P; Fearon M; Sheffield WP
    Transfus Med Rev; 2016 Apr; 30(2):53-68. PubMed ID: 26962008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogen reduction and blood transfusion safety in Africa: strengths, limitations and challenges of implementation in low-resource settings.
    Ware AD; Jacquot C; Tobian AAR; Gehrie EA; Ness PM; Bloch EM
    Vox Sang; 2018 Jan; 113(1):3-12. PubMed ID: 29193128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of rapid diagnostic tests for transfusion infectious screening in Africa: a literature review.
    Pruett CR; Vermeulen M; Zacharias P; Ingram C; Tayou Tagny C; Bloch EM
    Transfus Med Rev; 2015 Jan; 29(1):35-44. PubMed ID: 25447555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion safety: Where are we today?
    Luban NL
    Ann N Y Acad Sci; 2005; 1054():325-41. PubMed ID: 16339681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges.
    Bloch EM; Vermeulen M; Murphy E
    Transfus Med Rev; 2012 Apr; 26(2):164-80. PubMed ID: 21872426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion-Transmitted Infections: an Update on Product Screening, Diagnostic Techniques, and the Path Ahead.
    Dean CL; Wade J; Roback JD
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29669792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safe blood transfusion practices.
    Bharucha ZS
    Indian J Pediatr; 2001 Feb; 68(2):127-31. PubMed ID: 11284180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaches to minimize infection risk in blood banking and transfusion practice.
    Lindholm PF; Annen K; Ramsey G
    Infect Disord Drug Targets; 2011 Feb; 11(1):45-56. PubMed ID: 21303341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood transfusion safety in sub-Saharan Africa: A literature review of changes and challenges in the 21st century.
    Weimer A; Tagny CT; Tapko JB; Gouws C; Tobian AAR; Ness PM; Bloch EM
    Transfusion; 2019 Jan; 59(1):412-427. PubMed ID: 30615810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infectious diseases and the impact on transfusion medicine: A historical review and lessons for the future.
    Dutra VF; Bonet-Bub C; Sakashita AM; Kutner JM
    Transfus Clin Biol; 2023 Nov; 30(4):376-381. PubMed ID: 37328129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine.
    Hillyer CD; Josephson CD; Blajchman MA; Vostal JG; Epstein JS; Goodman JL
    Hematology Am Soc Hematol Educ Program; 2003; ():575-89. PubMed ID: 14633800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How do we … integrate pathogen reduced platelets into our hospital blood bank inventory?
    Rutter S; Snyder EL
    Transfusion; 2019 May; 59(5):1628-1636. PubMed ID: 30883807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current debate on pathogen inactivation of platelet concentrates--to use or not to use?
    Hervig T; Seghatchian J; Apelseth TO
    Transfus Apher Sci; 2010 Dec; 43(3):411-414. PubMed ID: 21075686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.